Breech Pelvimetry by EOS® Technique With Change of Maternal Position and Delivery Route
NCT ID: NCT05224908
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2022-01-26
2025-02-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
If the patient wishes to have a vaginal delivery, the pregnancy will be continued without intervention until spontaneous labour or induction in case of indication (premature rupture of membranes (PMR), over term, or intercurrent maternal or fetal pathology). The modalities of the delivery route and/or a possible induction will be discussed between the obstetric team and the patient.
If the patient wishes a caesarean delivery in case of persistent PS, the delivery will be scheduled after 39+0SA or earlier if indicated (RPM, intercurrent maternal or fetal pathology). In the case of a successful VME with a fetus that remains in cephalic presentation until labour, management will follow current recommendations. The characteristics of the dimensions and angles of the obstetric pelvis and the height of the fetal presentation in the standing and sitting positions, the performance and success of MEC, the choice of delivery route, and the final delivery route will be recorded.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In Vivo Assessment of the Elastic Properties of Women's Pelvic Floor During Pregnancy
NCT03602196
Evaluation of the Efficacy and Safety of an Equimolar Mixture of Oxygen and Nitrous Oxide in External Cephalic Version (ECV)
NCT01948115
Induction of Labor in Breech Presentation
NCT07071662
Investigating Women's Views on the Management of a Breech Pregnancy
NCT02082795
Prediction of Preterm Delivery with Serial Cervical Length Measurements After Threatened Preterm Labor
NCT05044143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Information about the study will be given by the investigator or his delegates during the presentation ultrasound.
After sufficient time for reflection and consent, EOS® pelvimetry in the upright and sitting position will be performed, starting at 36+0SA, and prior to attempted external manoeuvre version (EMV). The EOS® pelvimetry will be performed in the radiology department of the Clermont-Ferrand University Hospital, Estaing site. No other irradiating examination will be carried out, such as a pelvic CT scan, which will be replaced by pelvimetry using the EOS® system.
The examination will initially be carried out in the standing position, then in the sitting position on a stool.
A marker on the floor represented by two footprints will allow the straight standing and sitting images to be taken with equivalent and reproducible angles of femoral rotation.
The parameters assessed from the images taken by the EOS® system will be in the standing and sitting positions:
* The height of the fetal presentation assessed by measuring the distance between the centre of the maternal bisecting diameter and the lowest fetal trochanter.
* The angle of fetal progression,
* The median transverse diameter (MT),
* Promonto-retro-pubic distance (PRP),
* Magnin's index,
* Measurement of the sacral cord,
* Measurement of the sacral spire,
* Bispinous diameter,
* Bischial diameter,
* Subsacro-subpubic diameter,
* Pelvic angle of incidence,
* Pelvic obliquity,
* coxofemoral angle measurement.
After having been informed of the results of the pelvimetry performed in the upright position only (report and pictures), the performance of a VME will be proposed (the results of the pelvimetry in the sitting position will be transmitted after delivery, for statistical analysis).
If the patient wishes, an attempt at VME in the maternity ward of the Clermont-Ferrand University Hospital can be programmed from 36+0SA in accordance with the recommendations.
In the event of a successful MVA with a fetus that remains in cephalic presentation until labour begins, management will follow current recommendations.
In the event of refusal or failure of VME, the different delivery options will again be explained to the patient in accordance with the recommendations.
If the patient wishes to have a vaginal delivery, the pregnancy will be continued without intervention until spontaneous labour or induction if indicated (premature rupture of membranes (PMR), overdue delivery, intercurrent maternal or fetal pathology). The modalities of the delivery route and/or a possible induction will be discussed between the obstetric team and the patient.
If the patient wishes a caesarean delivery in case of persistent PS, the delivery will be scheduled from 39+0SA or earlier in case of indication (RPM, intercurrent maternal or fetal pathology).
The characteristics of the dimensions and angles of the obstetrical pelvis and the height of the fetal presentation in the standing and sitting positions, the performance and success of a VME, the choice of the delivery route and the actual delivery route will be recorded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pregnant women with a breech fetus
pregnant women with a breech fetus performing standing and sitting EOS pelvimetry
EOS
pelvimetry by EOS in standing and sitting position
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EOS
pelvimetry by EOS in standing and sitting position
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to give informed consent to participate in the research.
* Enrolled in a Social Security scheme.
Exclusion Criteria
* Pelvimetry by CT scan already performed
* Fetal malformation
* History of pelvic fracture
* Known uterine malformation that precludes VME (unicornuate uterus, uterine septum...)
* Contraindication to vaginal delivery (placenta previa, obstacle previa, bicatric uterus, ...)
* Patient under guardianship or legal protection
* Refusal to participate
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benoit Chauveau
Role: STUDY_DIRECTOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU clermont-ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-A01752-39
Identifier Type: OTHER
Identifier Source: secondary_id
RBHP 2021 CHAUVEAU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.